The WpCNA analysis further uncovered key phosphopeptides including Arhgap33 through individual and group level analysis that were associated with cognitive decline and tauopathy, synaptic dysfunction, and metabolic disruption, shedding light on potential therapeutic targets guided at associative learning and CA3 mossy fiber pathways. This evidence concerns the gene ARHGAP33 and tauopathy.